In vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antimicrobials: survey of Russian isolates. 1996

S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
National Research Center for Antibiotics, Nagatiskaya 3a, St. 113105, Moscow, Russian Federation.

Methodological differences makes it difficult to compare results of antimicrobial susceptibility testing obtained in Russia and in other regions. During the period from October 1993 to May 1994 susceptibility of 1296 isolates of bacteria was investigated according to NCCLS standards by the broth microdilution method. The order of activity of antibiotics against Gram-negative bacteria based on percent of susceptible strains from common hospitals were: amikacin (98%) > ciprofloxacin (93%) = imipenem (93%) > cefoperazone/sulbactam (92%) > ceftazidime (89%) > ceftriaxone (81%) > cefotaxime (80%) > cefoperazone (77%) > gentamicin (71%) > ampicillin/sulbactam (51%) > cefazoline (45%) > ampicillin (25%). The order of activity against strains from teaching hospitals was similar but the percent of susceptible strains was 10-20% less for the majority of antibiotics. The susceptibility level of Gram-negative isolates from Moscow teaching hospitals is lower than from Northern America and Europe. Ampicillln/sulbactam and cefoperazone/sulbactam, as well as other cephalosporins, demonstrated high activity against methicillin-susceptible staphylococci and penicillin-susceptible pneumococci. B-lactams/beta-lactamase inhibitor combinations were active against 100% strains of anaerobic bacteria.

UI MeSH Term Description Entries

Related Publications

S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
July 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
January 1990, Diagnostic microbiology and infectious disease,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
January 1990, Diagnostic microbiology and infectious disease,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
January 1989, Diagnostic microbiology and infectious disease,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
November 1993, The Journal of antimicrobial chemotherapy,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
November 1985, Diagnostic microbiology and infectious disease,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
October 1995, Zhonghua nei ke za zhi,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
November 2012, The Journal of the Association of Physicians of India,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
September 1990, Antimicrobial agents and chemotherapy,
S V Sidorenko, and S P Rezvan, and A S Tikchonova, and L A Krotova, and L E Ansolis, and E A Tzvigun
December 1995, The Malaysian journal of pathology,
Copied contents to your clipboard!